FAIRFAX, Va., Feb. 8, 2017 /PRNewswire-USNewswire/ -- Riad Salem, M.D., MBA, FSIR, will receive the Society of Interventional Radiology Foundation Leaders in Innovation Award on March 7, during the Society of Interventional Radiology's (SIR) Annual Scientific Meeting in Washington, D.C.

"I am honored and humbled to be recognized by my peers with the SIR Foundation Leaders in Innovation Award," said Salem, a professor of radiology, medicine and surgery at Northwestern University Feinberg School of Medicine, Northwestern Memorial Hospital, in Chicago. "This award represents another triumph of our specialty and cements the principles of interventional oncology as an integral component of modern interventional radiology and cancer care. It is the culmination of a decade-long vision of structured research and development towards a new treatment paradigm. Radioembolization is now recognized as a standard of care by international guidelines and has been incorporated by thousands of hospitals benefiting patients worldwide. For this experience, I am blessed."

"Dr. Riad Salem is a forward-thinking pioneer in the field of interventional radiology. His contribution to the art, science and practice of yttrium-90 radioembolization for liver malignancies opened the door for this now widely accepted treatment for many patients who simply had no other options," said Filip Banovac, M.D., FSIR, SIR Foundation chair and chief of vascular and interventional radiology at Vanderbilt University Medical Center, Nashville. "The entire field of interventional radiology owes him a great deal of gratitude for his innovative work."

The Dr. Gary J. Becker Young Investigator Award recognizes promising young practitioners to encourage the pursuit of academic careers. This year's recipient is Terence Gade, M.D., PhD, Hospital of the University of Pennsylvania, Philadelphia. Gade is co-founder and co-director of the Penn Image-Guided Interventions Laboratory, which has enabled research focusing on interventional oncology and vascular biology. Among other efforts, his innovative use of animal models has evolved the study of chemoembolization in vivo and allows interventional radiologists to characterize the cellular response to the treatment.

"Although still early in his career, his work is a model to all of us of who understand the importance of translational research in interventional radiology," said Banovac. "We look forward to many future contributions that Dr. Gade will make to our field."

X-Ray Homepage